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1
The prion protein in neuroimmune crosstalk
Indeed, no easily recognizable phenotypes are associate with a lack of PrP C , except the potentially advantageous trait that animals without PrP C cannot develop prion disease. This is because, in prion diseases, PrP C converts to a pathogenic "scrapie" conformer, PrP Sc , which aggregates and eventually induces neurodegeneration. In addition, endogenous neuronal PrP C serves as a toxic receptor to mediate prion-induced neurotoxicity. Thus, PrP C is an interesting target for treatment of prion diseases. Although loss of PrP C has no discernable effect, alteration of its normal physiological function can have very harmful consequences. It is therefore important to understand cellular processes involving PrP C , and M A N U S C R I P T
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3 1 Background
Prion diseases
The prion protein is known for its pivotal role in prion diseases, such as Creutzfeldt-Jakobs disease in humans, bovine spongiform encephalopathy in cattle, and scrapie in small ruminants. Prion disease belong to a group of neurodegenerative disorders characterized by accumulation of pathogenic protein aggregates within and around neurons (Kovacs and Budka 2008) . Such brain proteinopathies include prevalent human diseases like Alzheimer's and Parkinson's diseases. Prion diseases may be inherited, sporadic or infectious, and, in accordance with the original "protein-only" hypothesis (Prusiner 1982) , animals that do not express PrP C (Prnp knockout) do not replicate prions and are therefore resistant to prion diseases (Büeler et al. 1993; Prusiner et al. 1993) . During prion disease, PrP C levels decrease (Mays et al. 2014b) and physical interactions between endogenous PrP C and pathogenic PrP Sc conformers probably divert PrP C away from its physiological partners. This may lead to a loss of function and, importantly, a potential gain in PrP C -mediated toxic signaling with resultant neuronal death . Clearly, corruption of the normal cellular function of PrP C can have adverse effects on neuronal viability, highlighting the need for a better understanding of PrP C physiology.
Biogenesis and structure of PrP
C
The prion protein gene, PRNP, encodes a 253 amino acid (aa) precursor protein with an endoplasmic reticulum (ER)-targeting sequence for translocation into the secretory route. During transit through the ER and Golgi apparatus, PrP C is modified by two complex asparagine-linked sugar moieties, a disulfide bond, and a C-terminal glycosylphosphatidylinositol (GPI) anchor, localizing the protein to glycolipid-enriched membrane domains (Tatzelt and Winklhofer 2004) . NMR studies have shown that the N-terminal half of the protein, of about 100 aa, is unstructured, whereas the C-terminal half is a well-structured globular domain containing three α-helices and two short, antiparallel β-sheets (Donne et al. 1997; Lysek et al. 2005; Riek et al. 1996; Riek et al. 1997; Zahn et al. 2000 ) (Figure 1 ). A range of proteins interact with the N-terminal flexible tail (Béland and Roucou 2012) , but the functional implications of these interactions have been identified for only a few molecules. Considering the evolution of PrP C , it is interesting to note that the three-dimensional structure of the globular domain of human (aa 121-230), chicken (aa 121-225), turtle (aa 121-225), and frog (aa 90-222) PrP C show extensive similarities, indicating conserved activity .
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4 GPI-anchored PrP C at the cell surface, is ideally placed for moving between membrane domains and for interacting with transmembrane signaling complexes (reviewed in Linden 2017). Moreover, proteolytic cleavage can result in PrP C and PrP C -derived peptides being released to the inter-cellular space and interacting in immune signaling. PrP C can also form dimers and give rise to cis-and trans-PrP C interactions.
Towards a biological function of PrP
C
Soon after it had been discovered that PrP Sc is derived from the host-encoded PrP C , mice with genetic knockout (KO) of Prnp were generated. Surprisingly, the first two Prnp KO strains, Zürich I (ZrchI) and Edinburgh (Edbg), showed no developmental or other phenotypic disturbances (Büeler et al. 1992; Manson et al. 1994) . However, further investigations of Prnp-ablated mice have revealed subtle phenotypic changes, indicating possible functions for PrP C (Table 2) . Not surprisingly, the majority of these are related to the central nervous system (CNS), where PrP C is abundant. For instance, PrP C has been suggested to regulate circadian rhythms (Tobler et al. 1996) , participate in formation of memory (Coitinho et al. 2003) , and protect neurons from different types of stress, such as infarction (Weise et al. 2004) or apoptosis . Some of these findings have been influenced by the genetic backgrounds of the mouse strains used (reviewed in Wulf et al. 2017 ). However, a widespread, but clinically subtle, late-onset demyelination of the peripheral nervous system (PNS) has been discovered in mice without PrP C . This phenotype, which was not identified for twenty years, has been reported from both ZrchI and Edbg mice (Bremer et al. 2010) , and also in the more recent ZrchIII line (Küffer et al. 2016; Nuvolone et al. 2016) . This makes it the best characterized pathology caused by loss of PrP C function.
Other proposed PrP C functions apparently become evident under stressful conditions, such as inflammation. In this review, we discuss interactions between PrP C and the immune system with emphasis on neuroimmune crosstalk. For recent reviews covering other aspects of PrP C physiology, see (Castle and Gill 2017; Wulf et al. 2017) . Acute cerebral infarction (Doeppner et al. 2015; Mitteregger et al. 2007; Shyu et al. 2005; Spudich et al. 2005; Steele et al. 2009; Weise et al. 2004 ).
Induction of apoptosis Lopes et al. 2005; Zanata et al. 2002) .
Excitotoxicity (Gasperini et al. 2015; Rambold et al. 2008) Genotoxic stress (Bravard et al. 2015; Senator et al. 2004; Watt et al. 2007) Oxidative stress (Anantharam et al. 2008; Bertuchi et al. 2012; Dupiereux et al. 2008) Inflammation (Gourdain et al. 2012; Hu et al. 2010; Tsutsui et al. 2008 ) Infection (Nasu-Nishimura et al. 2008) Brain trauma (Hoshino et al. 2003 )
Cellular differentiation
Neurite outgrowth in cultured cells (Beraldo et al. 2011; Bribián et al. 2012; Llorens et al. 2013; Lopes et al. 2005; Loubet et al. 2012; Santuccione et al. 2005) Neuronal excitability Electrophysiological recordings and kainate-induced seizures (Beraldo et al. 2010; Carulla et al. 2011; Colling et al. 1996; Khosravani et al. 2008; Mallucci et al. 2002 ) Modulation of circadian rhythms and sleep patterns Sleep deprivation (Huber et al. 1999; Sánchez-Alavez et al. 2007; Tobler et al. 1996 ) Behavior (locomotor activity, anxiety, nest-building behavior, aggression, and depressive-like behavior)
E.g., exploration of unfamiliar environment, electric foot shock, forced swimming, and tailsuspension test (Büdefeld et al. 2014; Coitinho et al. 2003; Gadotti et al. 2012; Lobão-Soares et al. 2007; Nico et al. 2005; Rial et al. 2009; Roesler et al. 1999; Schmitz et al. 2014) Cognitive performance and memory E.g., inhibitory avoidance task, Barnes circular maze test, and fear conditioning (Coitinho et al. 2003; Criado et al. 2005; Manson et al. 1995; Schmitz et al. 2014) Homeostasis of metals (copper, zinc, and iron) E.g., chromatography and coimmunoprecipitation (Gasperini et al. 2015; Hornshaw et al. 1995; Singh et al. 2009; Watt et al. 2012 )
Myelin maintenance (PNS)
Histopathology, electrophysiology, hot-plate test, grip-strength test, and rotarod performance test (Bremer et al. 2010; Küffer et al. 2016; Nuvolone et al. 2016 )
Mediate neurotoxic effects of other molecules
Scrapie prions (Prion diseases) (Brandner et al. 1996; Chesebro et al. 2005; Mallucci et al. 2003; Rambold et al. 2008 ) Amyloid beta (Alzheimer's disease) (Lauren et al. 2009; Purro et al. 2018; Resenberger et al. 2011) α-synuclein (Parkinson's disease) (Ferreira et al. 2017) M A N U S C R I P T
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6 2 PrP C and the immune system
The presence of PrP C throughout the nervous system and other immune-privileged organs like testicles and ovaries, combined with its presence in most immune cells, makes it ideally placed for participating in neuroimmune communication. In a previous review, we proposed the idea that PrP C could contribute to the broadly defined phenomenon of immunological quiescence . Indeed, subtle phenotypes observed under basal conditions in Prnp KO mice suggest that functions of PrP C in the immune system are modulatory and perhaps easier to identify during acute stress when there is activation of innate immune responses. Importantly, the presence of PrP C in both the immune system and the nervous tissues is not only relevant for the normal function of these cells, but plays a crucial role in the uptake, peripheral propagation, and dissemination of prions during prion infection (Donaldson et al. 2016; McCulloch et al. 2011; McCutcheon et al. 2011 ).
PrP C in blood immune cells
PrP C is expressed in immune-privileged stem-cell niches of the hematopoietic bone marrow and has been shown to be important for stem-cell renewal under stressful conditions (Zhang et al. 2006) . Generally, high levels of PrP C are maintained in mononuclear cell precursors, but it is downregulated during maturation of granulocytic and erythroid cell lines (Dodelet and Cashman 1998) . In humans, monocytes, lymphocytes, mast cells, neutrophils, platelets, and red blood cells all express PrP C , albeit at varying levels (Dürig et al. 2000; Haddon et al. 2009 ). Intriguingly, there appears to be species differences in PrP C expression on blood cells (Barclay et al. 2002; Holada and Vostal 2000) . In sheep and goats, resting granulocytes are negative for PrP C , whereas mononuclear cells, primarily lymphocytes and monocytes, are strongly positive (Dassanayake et al. 2012; Halliday et al. 2005; Herrmann et al. 2001; Reiten et al. 2015) .
Early investigations showed that cell-surface levels of PrP C are promptly upregulated when T cells are activated, and that genetic removal of Prnp or pharmacological blocking of PrP C impaired T-cell proliferation (Bainbridge and Walker 2005; Cashman et al. 1990; Mabbott et al. 1997) . Similarly, PrP C appeared to modulate cytokine production and proliferation of T cells induced by MHC-driven interactions with dendritic cells (Ballerini et al. 2006) . Furthermore, silencing of PrP C resulted in murine T cells being skewed towards proinflammatory phenotypes (Hu et al. 2010) . Interestingly, T-cell proliferation rates in PrP Cdeficient goats (Reiten et al. 2015) and cattle (Richt et al. 2007) were similar between cells with and without PrP C , demonstrating that a prominent role for PrP C in T-cell activation is not uniform among mammalian species. PrP C is also strongly upregulated in activated murine neutrophils in response to increased serum levels of TGF-β and glucocorticoids Mariante et al. 2012) . These molecules are reliant on the hypothalamic-pituitary-adrenal axis, which is activated by systemic inflammation. Another cell type with high PrP C expression is mast cells (Haddon et al. 2009 ). Although PrP C was not found to be obligatory for mast cell differentiation, it was rapidly shed from the cell surface upon activation, such as during mast cell-dependent allergic inflammation (Haddon et al. 2009 ). The functional implications of these findings remain to be clarified, but it can be speculated that release of PrP C into the surroundings can contribute towards balancing inflammatory signaling in paracrine fashion. Of importance, a sub-type of mast cells resides on the brain side of the blood-brain barrier and communicates with neurons, astrocytes, and microglia (Dong et al. 2014 ). Thus, upon activation, mast cells act as first responders to initiate, amplify, and prolong immune and nervous responses.
Another key element of immune responses and neuroimmune crosstalk is tissue invasion by activated blood leukocytes. Several studies have shown that PrP C modulates leukocyte extravasation (de Almeida et al. 2005; Linden et al. 2008; Liu et al. 2014) including into the CNS . A possible way by which PrP C can influence leukocyte migration is through interaction with adhesion molecules like β1 integrin (Richardson et al. 2015) , which is a co-receptor for PrP C (Loubet et al. 2012) . Alternatively, the reported differences could reflect increased levels of chemoattractants and cytokines in PrP C -deficient animals, rather than a direct effect of PrP C in leukocyte adhesion. Again, contradictory findings have been reported in other animal models, in which similar tissue recruitment of leukocytes was observed independent of PrP C expression (Gourdain et al. 2012; Salvesen et al. 2017a ).
Therefore, replication of murine studies on T-cell activation and leukocyte migration in the more recently developed co-isogenic Prnp KO lines could provide useful results.
PrP C in neuroinflammation
One frequently used approach to study multiple sclerosis-like neuroinflammation is induction of experimental autoimmune encephalomyelitis (EAE) by injection of myelin oligodendrocyte glycoprotein. EAE is a complex condition accompanied by aggressive brain inflammation, demyelination, axonal loss, and gliosis (Constantinescu et al. 2011 ). Studies of EAE in Prnp KO mice have shown that loss of PrP C exacerbates disease progression, with increased clinical severity and neuropathology, as well as higher transcription levels of proinflammatory cytokines, TNF-α and interleukin-1β, in comparison to that of PrP C -expressing wild-types (Gourdain et al. 2012; Hu et al. 2010; Tsutsui et al. 2008) . Mice overexpressing PrP C displayed a further reduction in neuroinflammation, suggesting that PrP C has neuroprotective functions during EAE in vivo (Hu et al. 2010) . The greater severity of EAE in Prnp KO mice was initially linked to increased pro-inflammatory signaling by PrP C -negative T M A N U S C R I P T
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8 cells (Hu et al. 2010 ), but a subsequent study suggested that neuronal lack of PrP C could play an important role as well (Gourdain et al. 2012) . Interestingly, PrP C was coimmunoprecipitated with the Zeta chain-associated protein kinase 70 (ZAP-70), which is a key component of the T cell-receptor complex (Mattei et al. 2004) . Moreover, reduced phosphorylation of ZAP-70 was observed in the presence of PrP C , providing evidence for a functional role for PrP C in dampening T-cell signaling (Hu et al. 2010) . Notably, PrP C has also been shown to have protective roles during inflammatory challenge in peripheral tissues, such as the spleen ) and colon (Martin et al. 2011 ).
Despite these various observations suggesting that PrP C plays a significant immunomodulatory role, particularly during inflammatory stress, the signaling pathways and molecular contexts involving PrP C are still largely unresolved. Some advances in our understanding have, however, been made in recent years. Ezpeleta and colleagues showed that PrP C could protect against TNF-α -mediated inflammation by stimulating cleavage of TFNR1, with subsequent release of soluble TNFR1 via the TACE α -secretase pathway, thus downregulating TNF-α signaling (Ezpeleta et al. 2017 ). TNF-α -mediated signaling has also been shown to regulate PrP C levels on brain microvascular endothelial cells (BMVEC), an important component of the blood-brain barrier (Megra et al. 2018) . Furthermore, knockdown of PrP C in BMVEC caused increased permeability of the blood-brain barrier, which is a significant event of neuroinflammation. These mechanisms may, at least partly, explain observations of increased TNF-α-driven inflammatory pathology in Prnp KO animals. Interestingly, studies of human melanoma and adenocarcinoma cells expressing an immature and incompletely processed form of PrP C , lacking its GPI anchor, have revealed that this non-functional PrP C species enhances pro-inflammatory TNF-α signaling (Wu et al. 2017 ). Accordingly, genetic removal of pro-PrP in these cells reduced inflammatory signaling.
Studies of experimental acute cerebral infarction have shown that mice without PrP C suffer larger infarction volumes than wild-type controls. This has been considered to be partly due to increased signaling and activation of ERK1/2, STAT1, and pro-apoptotic caspase-3 pathways in the absence of PrP C (Shyu et al. 2005; Spudich et al. 2005; Steele et al. 2009; Weise et al. 2004) . Correspondingly, reduced activation of the PI3K-Akt pathway, which is a negative regulator of caspase-3 signaling, was observed in Prnp KO animals (Weise et al. 2006) . Indeed, caspase 3 is a crucial mediator of neuronal apoptosis (Yang et al. 2002) and animals overexpressing PrP C had smaller infarction sizes and reduced post-ischemic ERK1/2 activation (Shyu et al. 2005; Weise et al. 2008) . Subsequently, interactions between stressinducible phosphoprotein-1 (STI1), a co-chaperone released by astrocytes (Hajj et al. 2013) , and PrP C have been ascribed protective functions against ischemia-derived pathology M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT (Beraldo et al. 2013; Zanata et al. 2002) . Both PrP C and STI1 are upregulated in the periphery of ischemic brains lesions of humans and rodents (Beraldo et al. 2013; Weise et al. 2004) , and the STI1/PrP C -interaction seemed to increase influx of bone marrow-derived cells into ischemic brain regions, thus triggering a self-protective mechanism to facilitate recovery after brain infarction (Lee et al. 2013) . Recently, neuroprotection by PrP C /STI1-signaling was shown to involve α7nAchR, in addition to activation of the neuronal activing A receptor, by increased levels of STI1 (Beraldo et al. 2018) . Notably, ischemic stroke comprises both an acute and prolonged inflammatory response (Jin et al. 2010) , and it is reasonable to assume the above-mentioned signaling overlaps with immunomodulatory signaling by PrP C .
At the cellular level, neuroimmune crosstalk is maintained through an integrative network of neurons, microglia, astrocytes, and infiltrating immune cells, such as T cells (Tian et al. 2012 ) (Figure 2 ). Importantly, all the cellular participants of neuroimmune crosstalk express Bertuchi et al. 2012; Moser et al. 1995) . A hallmark of acute neuroinflammation is activation of resident microglia, which participate in the phagocytosis of microbes or debris, as well as release of cytokines (Colonna and Butovsky 2017) . Early studies (Brown et al. 1998 ) using the immortalized murine microglia-like cell line BV2 indicated roles for PrP C in cellular activation and survival , also following infection with Mycobacterium bovis ). However, a further study using primary microglia failed to detect any effects of PrP C on cell morphology, microglial markers, phagocytosis rate, or cytokine production, even following activation (Pinheiro et al. 2015) .
The authors of the latter study suggest that caution should be used in interpreting results from BV2 immortalized-cell lines alone in studying PrP C function, as BV2 cells and primary microglia cultures differ in migration and cytokine production (Horvath et al. 2008 ).
Astrocytes also play significant roles in brain inflammation, producing both pro-and antiinflammatory chemokines (Kim et al. 2010) . Astrocyte end-feet encircle endothelial cells at the blood-brain barrier and enable close proximity to systemic circulation and immune cells that infiltrate the perivascular space (Rungta and Charpak 2016) . Although the subject of few studies, astrocyte PrP C seems to be important for the survival and differentiation of both astrocytes (Arantes et al. 2009 ) and neurons (Lima et al. 2007; Lopes et al. 2005) . Interestingly, astrocytes overexpressing PrP C showed higher levels of GFAP (Hartmann et al. 2013 ), a general marker of astrocyte activation and neuroinflammation. PrP C also protected astrocytes from oxidative stress (Bertuchi et al. 2012 ), which could be important during inflammation caused by infarctions. Nevertheless, mechanistic evidence of how astrocyte PrP C may modulate inflammation has not been clarified.
Taken together, these studies share the concept that PrP C protects against neuroinflammation, probably by modulating the effects of cytokines and other (Smith et al. 2003) , activation of T and dendritic cells (Latour et al. 2001) , and transendothelial migration of neutrophils (Cooper et al. 1995 ) and monocytes (de Vries et al. 2002) . Therefore, the use of loss-of-function phenotypes alone to address PrP C function should be done with caution.
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Proteolytic processing of PrP C : signaling by PrP C fragments
Mature PrP C can be subject to proteolytic processing (Harris et al. 1993; Stahl et al. 1990 ). 
2009
; Mitteregger et al. 2007 ). In addition to binding to cell-surface receptors, it is also plausible that the N1 fragment can interact with nearby cells and/or enter cells to reach intracellular compartments. Importantly, the polybasic motif in the N-terminal domains of PrP C (K 23 KRPK) resembles the trans-activating transcriptional activator peptide from human M A N U S C R I P T
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11 immunodeficiency virus 1, and therefore has cell-penetrating activity (Lundberg et al. 2002; Wadia et al. 2008 ). Thus, N1 may enter the cell and interact with cytosolic components after it is liberated from GPI-anchored PrP C . The N-terminal part of PrP C has nucleic acid-binding properties with affinity for both DNA and RNA (Murdoch et al. 1990; Sklaviadis et al. 1993) and may adopt chaperon-like roles, resembling retroviral nucleocapsid proteins (Gabus et al. 2001; Manuelidis et al. 1995) . Further roles for PrP C -derived fragments, most notably N1, in the cellular household of cytoplasmic nucleic acids is an intriguing topic for further exploration, directly linked to basal (tonic) innate immunity signaling and putative effects on gene expression.
It has been shown that chronic lymphocytic inflammation with activated B cells and stromal follicular dendritic cells leads to focal upregulation of PrP C , and that such inflammatory loci can sustain prion replication in otherwise prion-free organs (Heikenwalder et al. 2005) . As full-length PrP C can be shed from immune cells (Haddon et al. 2009; Parizek et al. 2001 (Krebs et al. 2006) . The true physiological relevance of this and similar studies (Jeon et al. 2013; Seong et al. 2015) remains to be established. In transgenic mice, a secreted artificial PrPimmunoglobulin Fc (PrP-Fc 2 ) fusion protein that forms disulfide bond-stabilized dimers was not converted into PrP Sc and delayed onset of prion disease (Meier et al. 2003) .
Interestingly, transgenic mice overexpressing a secreted variant of PrP C devoid of the Cterminal GPI signal sequence (PrP∆GPI), spontaneously develop neurodegenerative prion disease with striking similarities to a sub-set of Gerstmann-Sträussler-Scheinker disease (Stöhr et al. 2011 ). This demonstrates that secreted PrP C can be amyloidogenic and potentially harmful, suggesting that shedding of full-length PrP C , at least in the brain, must be a tightly controlled process.
3 PrP C -deficient goats: a spontaneous animal model to study immune signaling by PrP 
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12 not have PrP C , and their PRNP mRNA levels are strongly reduced (Reiten et al. 2015; Salvesen et al. 2017a ), probably through nonsense-mediated mRNA decay mechanisms. In a genetic survey of 1 984 goat bucks in Norway, 216 (10.9 %) animals carried the mutation, of which 13 (0.7 %) were homozygous (unpublished results). Since its discovery, we have carried out a series of investigations of this unexpected, and apparently unique, nontransgenic "PrP C knockout" model. New phenotypes could shed light on PrP C physiology and cross-validate studies primarily carried out in inbred transgenic mouse models. Drawbacks to studies using this goat line are their outbred nature, with high individual variation, their slow reproductive capacity, and the high costs associated with housing and maintenance of the animals. However, goats have a longer life-expectancy than laboratory rodents and are natural hosts for prion disease. In addition, they are housed under standard goat husbandry conditions, with normal development of the intestinal gut flora and immune system, including responsiveness to vaccines. This is in contrast to the specific pathogen free (SPF) facilities used in housing laboratory rodents; such abnormally hygienic environments can profoundly impact the cellular composition of the innate and adaptive immune system (Beura et al. 2016) , such that the immunomodulatory roles of PrP C may be masked or camouflaged, and results obtained may be misleading. Goat kids raised in a goat herd are also required to develop social and behavioral characteristics according to flock standards, set by adult dominant females; although more than 50 animals without PrP C have been bred and raised in our goat-herd facilities, we have not observed any behavioral abnormalities, such as anxiety or hyper-sensitivity towards triggers such as noise. However, detailed behavioral analyses have not yet been performed.
2 Subtle, but striking, phenotypes in PrP C -deficient goats
An initial assessment of clinical, hematological, and immunological parameters of goats without PrP C , revealed that animals without PrP C had higher red blood cell counts, with slightly reduced cell volumes, than normal goats. The difference was subtle and clinically insignificant, but closer analyses reveled a gene-dose effect, with heterozygous animals showing an intermediate shift of the hematological profile (Reiten et al. 2015) . This is strikingly similar to that observed in cattle with genetic ablation of PRNP, in which a virtually identical phenotype was noted (Richt et al. 2007 ). Thus, in two ruminant species, with obviously different genetic backgrounds, loss of PrP C induced hematological alterations. In both species, this probably reflects an influence of PrP C in bone marrow hematological stem-cell niches. Morphological analysis of bone marrow in goats without PrP C did not reveal any obvious alterations, but further investigations on this topic, including the use of co-isogenic transgenic mice, should be considered. Analysis of monocyte phagocytic capacity in vitro showed that cells performed similarly, regardless of PrP C status (Reiten et 
al. 2015). These observations suggest, as pointed out by Nuvolone and co-workers (Nuvolone et al. 2013) , that some of the previously reported phenotypes may have been skewed by flanking genes, like Sirpa. Nevertheless, altered phagocytic ability has also been described in bone marrow-derived Prnp 0/0 macrophages infected with Escherichia coli (Wang et al. 2014) . Since E. coli do not express CD47, which is the main ligand for SIRPα, the authors attributed their findings mainly to PrP C . Thus, further studies are required to clarify the relationship between PrP C and other molecules important for phagocytosis.
Based on the knowledge that goat peripheral blood mononuclear cells (PBMCs) have robust cell-surface PrP C expression, a transcriptomic analysis of PBMCs was carried out (Malachin et al. 2017 ). In accordance with expectations and data from mice, only a minute fraction of genes was differentially expressed between the genotypes. However, in the absence of PrP C , a mild increase in basal expression of type I interferon-stimulated genes (ISGs) was dominant (Malachin et al. 2017) . This unexpected observation suggests that, at some currently unidentified level, PrP C , influences resting-state innate immunity signaling.
Cellular regulation of basal expression levels of ISGs is complex and multilayered, including crosstalk with gut microbiota and epigenetic mechanisms (reviewed in Ivashkiv and Donlin 2014) . Given the extreme sensitivity of ISGs to interferon stimuli, even a mild sub-clinical infection could underlie expression differences between animals (Lathe and Darlix 2017). However, our initial study included eight age-matched clinically healthy animals of each genotype from the same flock at the same time-point, and therefore it is unlikely that one of the groups should selectively carry a sub-clinical viral infection. Moreover, subsequent studies of further groups of goats, of different ages and housed under different conditions, have shown the same gene expression difference between the groups (Salvesen et al. 2017a; Salvesen et al. 2017b) .
In an experiment with acute inflammation caused by intravenous injection of E.coli-derived lipopolysaccharide (LPS), goats without PrP C displayed significantly prolonged sickness behavior, dominated by depression and lack of interest in the surroundings (Salvesen et al. 2017a ). Expression levels of the primary inducers of sickness behavior, IL-1β and TNF-α, were not altered in the brain at the time of euthanasia, but a transient increase almost immediately after LPS challenge is likely (Marques et al. 2009 ). As described previously, higher levels of these cytokines have been described in a range of Prnp KO models Martin et al. 2011; Tsutsui et al. 2008) , and could potentially contribute to the prolonged sickness behavior in goats. Although reports of LPS-induced sickness behavior in
Prnp-ablated mice are lacking, a depressive-like behavior during standardized stress tests has been described (Gadotti et al. 2012) . The profound sickness behavior in PrP C -deficient goats corresponded with higher body temperatures over a prolonged period after LPS M A N U S C R I P T
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14 injection. Gene expression profiling of the hippocampus and choroid plexus (part of the blood-brain barrier) showed that PrP C -deficient goats had a relatively stronger increase in expression levels of ISGs, but the opposite was the case for genes that are predominantly regulated by type II interferon (Salvesen et al. 2017a) . Morphological analysis and activation scores for microglia and astrocytes appeared similar between the genotypes in both tissues.
Further analysis of lung parenchyma, which is severely affected by LPS challenge, showed that goats without PrP C had higher expression levels of genes downstream from inflammatory regulators like TNF-α, IL-1β and INF-γ (Salvesen et al. 2017b) . (Gourdain et al. 2012; Hu et al. 2010; Tsutsui et al. 2008 )
Encephalomycarditis infection
Suppressed microglial response Reduced leukocyte infiltration Increased neuronal apoptosis is attached to the cell membrane through its GPI-anchor. Ligands can bind PrP C which probably is associated with transmembrane co-receptors to initiate signaling into the cell. Shedding of PrP C can be performed in close proximity to the GPI-anchor releasing soluble PrP C into the extracellular space (1). The N-terminal domain (N1 fragment) can be released by α-cleavage leaving membrane bound C1 (mC1) attached to the cell surface (2). Finally, the C1 fragment can be shed form the cell surface in a soluble form sC1 (3). The released PrP C fragments can probably mediate both intercellular communication (paracrine) and autocrine signaling. 
